Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 10, 2010, Pages 1144-1146

  Mateen, Farrah J ^a,b   Carone, Marco ^b   Sorenson, Eric J ^a  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVAL; UNITED STATES; MIDDLE AGED; MORTALITY; ONSET AGE; STATISTICS; SURVIVAL RATE; SURVIVOR;

ADULT; AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; SURVIVAL RATE; SURVIVORS;

EID: 77958121094     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.201251     Document Type: Article

References (19)

1. Rowland LP. How amyotrophic lateral sclerosis got its name. Arch Neurol 2001;58:512-15.
2. Swank RL, Putnam TJ. Amyotrophic lateral sclerosis and related conditions. Arch Neurol Psych 1943;49:151-77.
3. Mulder DW, Howard FM Jr. Patient resistance and prognosis in amyotrophic lateral sclerosis. Mayo Clin Proc 1976;51:537-41.
4. Turner MR, Parton MJ, Shaw CE, et al. Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. J Neurol Neurosurg Psychiatry 2003;74:995-7.
5. Norris F, Shepher R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48-55. (Pubitemid 23269966)
6. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci 1994;124:96-107.
7. Agresti A. Categorical Data Analysis. New York: John Wiley & Sons, 2002.
8. Rosner BA. Fundamentals of Biostatistics. Pacific Grove, CA: Duxbury, 2006.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
10. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2008.
11. Mortara P, Chiò A, Rosso MG, et al. Motor neuron disease in the province of Turin, Italy, 1966-1980. J Neurol Sci 1984;66:165-73.
12. Rosen AD. Amyotrophic lateral sclerosis clinical features and prognosis. Arch Neurol 1978;35:638-42.
13. Zoccolella S, Beghi E, Palagano G, et al. Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci 2008;268:28-32. (Pubitemid 351395319)
14. Chío A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10:310-23.
15. Christensen PB, Højer-Pederson E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in 2 Danish counties. Neurology 1990;40:600-4.
16. Preux PM, Couratier P, Boutros-Toni F, et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology 1996;15:153-60.
17. Chancellor AM, Slattery JM, Fraser H, et al. The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993;240:339-46. (Pubitemid 23230381)
18. del Aguila MA, Longstreth WT Jr, McGuire V, et al. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813-19. (Pubitemid 36297366)
19. Wijesekera LC, Mathers S, Talman P, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009:1087-94.